Sleeper Meg M, O'Donnell Patricia, Fitzgerald Caitlin, Papich Mark G
Department of Clinical Studies, University of Pennsylvania Veterinary School, Philadelphia, PA, USA.
Department of Pathobiology, University of Pennsylvania Veterinary School, Philadelphia, PA, USA.
J Feline Med Surg. 2019 Oct;21(10):882-886. doi: 10.1177/1098612X18805879. Epub 2018 Oct 19.
The aim of this study was to determine the pharmacokinetics of furosemide in cats following intravenous (IV), oral and transdermal administration.
This study used six healthy adult cats in a three-phase design to compare plasma furosemide concentrations in cats that received one IV 2 mg/kg dose of furosemide, one oral 2 mg/kg dose of furosemide and 3 days of q12h dosing with 2 mg/kg furosemide transdermally applied to the ear pinna.
After IV administration the elimination half-life was (mean and coefficient of variation) 2.25 h (72%), systemic clearance was 149 ml/kg/h (27.4%) and volume of distribution was 227 ml/kg (22%). After oral administration the terminal half-life was 1.2 h (18.7%), peak concentration was 3.4 μg/ml (51.7%) and bioavailability was 48.4%. The transdermal plasma concentrations were undetectable or very low at most time points, and pharmacokinetics were not determined from the transdermal dose.
Furosemide was rapidly eliminated in cats after oral and IV administration and is probably best administered orally at least q12h in cats with heart failure. The oral dose absorbed was approximately 50%, but the absorption from transdermal administration was negligible.
本研究旨在确定呋塞米在猫经静脉注射(IV)、口服和经皮给药后的药代动力学。
本研究采用六只健康成年猫,采用三阶段设计,比较接受一剂2mg/kg静脉注射呋塞米、一剂2mg/kg口服呋塞米以及连续3天每12小时在耳廓经皮给予2mg/kg呋塞米的猫的血浆呋塞米浓度。
静脉给药后,消除半衰期为(均值和变异系数)2.25小时(72%),全身清除率为149ml/kg/h(27.4%),分布容积为227ml/kg(22%)。口服给药后,终末半衰期为1.2小时(18.7%),峰浓度为3.4μg/ml(51.7%),生物利用度为48.4%。在大多数时间点,经皮给药后的血浆浓度无法检测到或非常低,因此未根据经皮给药剂量确定药代动力学。
呋塞米在猫经口服和静脉给药后迅速消除,对于心力衰竭的猫,可能至少每12小时口服给药一次最为适宜。口服吸收剂量约为50%,但经皮给药的吸收可忽略不计。